PicturaBio delivers imaging and ML-based pathogen detection with a dedicated imager, single-use cartridges, and analysis software.
PicturaBio has raised $9.1M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in September 2026.
PicturaBio's investors include Sunway iLabs.
PicturaBio is headquartered in Oxford, United Kingdom.
PicturaBio delivers imaging and ML-based pathogen detection with a dedicated imager, single-use cartridges, and analysis software.
PicturaBio is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"PicturaBio — Funding & Investors." VCBacked, September 23, 2026, https://www.vcbacked.co/company/picturabio. Accessed October 1, 2026.
VCBacked. (2026). PicturaBio — Funding & Investors. Retrieved October 1, 2026, from https://www.vcbacked.co/company/picturabio
{{cite web |title=PicturaBio — Funding & Investors |url=https://www.vcbacked.co/company/picturabio |website=VCBacked |access-date=October 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated